Abingworth

Abingworth as of Dec. 31, 2011

Portfolio Holdings for Abingworth

Abingworth holds 25 positions in its portfolio as reported in the December 2011 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amarin Corporation 36.6 $59M 7.9M 7.48
Clovis Oncology 11.3 $18M 1.3M 14.01
Micromet 9.3 $15M 2.1M 7.17
Alnylam Pharmaceuticals (ALNY) 9.2 $15M 1.8M 8.14
Incyte Corporation (INCY) 7.7 $12M 830k 14.99
Astex Pharmaceuticals 5.2 $8.4M 4.5M 1.88
OncoGenex Pharmaceuticals 4.4 $7.0M 604k 11.67
Zogenix 3.2 $5.2M 2.3M 2.22
Nektar Therapeutics (NKTR) 2.3 $3.7M 664k 5.59
Alexza Pharmaceuticals 1.5 $2.4M 2.9M 0.82
Medicines Company 1.2 $2.0M 107k 18.64
Exelixis (EXEL) 1.2 $2.0M 415k 4.73
ISIS Pharmaceuticals 1.2 $1.9M 268k 7.20
Novavax 1.2 $1.9M 1.5M 1.24
Trimeris 1.1 $1.7M 64k 26.61
Cardiome Pharma Corp 0.8 $1.3M 481k 2.62
Isis Pharmaceuticals Inc Del note 2.625% 2/1 0.7 $1.2M 1.3k 900.00
Zalicus 0.6 $1.0M 864k 1.20
Celldex Therapeutics 0.6 $886k 343k 2.58
Cornerstone Therapeutics 0.3 $473k 85k 5.58
Allos Therapeutics 0.2 $374k 265k 1.41
AVANIR Pharmaceuticals 0.1 $230k 113k 2.04
Sunesis Pharmaceuticals 0.1 $149k 129k 1.15
EntreMed 0.0 $67k 71k 0.95
Poniard Pharmaceuticals (PARD) 0.0 $10k 4.6k 2.19